DO WHAT YOU SAY !!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Cisco (CSCO)
Cisco Systems shares jumped 10% after the networking tech giant’s third-quarter revenue guidance came in above Wall Street expectations.
The company sees third quarter revenue up 11% to 13% year-over-year. Cisco also raised its full year 2023 adjusted earnings per share view to $3.73-$3.78 from $3.51-$3.58.
Cisco’s second-quarter earnings per share of 88 cents beat estimates of 85 cents while $13.6 billion in sales came in line with expectations of $13.6 billion.
Cisco Systems, Inc. (CSCO)View quote details
NasdaqGS - Nasdaq Real Time Price (USD)
48.45+0.75(1.57%)
At close: 4:00PM EST
50.00 +1.55 (+3.20%)
After hours: 7:42PM EST
AMIH !! ON THE MOVE !!
DCFC ! JUST POPPED THE SAR ! Look at it go .....thanks
GDVM ! VEEMOST BLUE SKIES !
DCFC ! I LIKE-IT ! There making money to.
GDVM ! LAST CHANCE BEFORE BLUE-SKY-BREAK-OUT !!
GDVM! VEEMOST LOOKS TO HIT BLUE SKIES TODAY !!
QBIO ! BB"S OPENING HERE ! On 5min hang-on-to-your-hats !! 5 min >>>
https://www.barchart.com/stocks/quotes/QBIO/technical-chart?plot=CANDLE&volume=total&data=I:5&density=H&pricesOn=1&asPctChange=0&logscale=0&im=5&indicators=BBANDS(20,2);SMA(20);SMA(50);SMA(100);SMA(200);ACCUM;AROONOSC(25);ATR(14);CHKMF(20);STOFA(14,3);MFI(14,100);MACD(12,26,9);RSI(14,100);TRIX(3.3);ADXMOD(14);AROON(25)&sym=QBIO&grid=1&height=500&studyheight=100
QBIO ! NICE BID ! Somebody has some brains........gl
GDVM ! WHO IS THAT DUMMY ! That just lost his shares at .108 o-will-he-be-sorry .... o-well
GDVM ! HANG-ON-TO-YOUR-HATS-FOLKS ! BB"S opening-up here on 5 min chart its a good start.....gl
GDVM ! O-BOY LOOKY AT THEM BB "S ! !! On the 5 min chart TOTHE will it go the right way i bet it does look for them bb"s to start to open on 5 min chart >>>
https://www.barchart.com/stocks/quotes/GDVM/technical-chart?plot=CANDLE&volume=total&data=I:5&density=H&pricesOn=1&asPctChange=0&logscale=0&im=5&indicators=BBANDS(20,2);SMA(20);SMA(50);SMA(100);SMA(200);ACCUM;AROONOSC(25);ATR(14);CHKMF(20);STOFA(14,3);MFI(14,100);MACD(12,26,9);RSI(14,100);TRIX(3.3);ADXMOD(14);AROON(25)&sym=GDVM&grid=1&height=500&studyheight=100
Global Developments Holdings, Inc Executes Merger with VeeMost Technologies, LTD – A Cloud and Cybersecurity Company
Press Release | 02/14/2023
Wilmington, DE, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Global Developments Holdings, Inc. (OTC: GDVM) and VeeMost Technologies, LTD have entered into a merger agreement through the exchange of preferred shares. As a result of the merger, Global Developments Holdings, Inc. has been renamed to VeeMost Technologies Holdings, Inc., and an application has been submitted to FINRA to change the issuer's name, ticker symbol, and CUSIP.
Founded in 2002, VeeMost is a team of experienced industry leaders and professionals led by its chief executive officer, Mr. Melvin Ejiogu, who holds a bachelor's degree in Business Administration with a specialization in Corporate Finance from the University of Akron, Ohio. In addition to having over 25 years of experience in the technology industry, Melvin holds numerous top-level I.T certifications, including the Cisco Certified Internetwork Expert (CCIE) certification.
Melvin has achieved success at multiple IT organizations including his prior partnership with Fit Technologies in Cleveland, Ohio. In this role, he served as Director of Business Development and Director of Technology Engineering, contributing significantly to the company's growth and success. Melvin also served with AT&T Labs as a Lead Principal Architect & Designer. There, he led a highly specialized team of experts and was crucial in the design, implementation, and delivery of customized and secured network infrastructures, products, and solutions to large government agencies and enterprises.
In his first full year back at VeeMost as CEO and President, Melvin has built a strong foundation. He has set his sights on replicating his success at VeeMost and taking the company to new heights. As a result of this vision, VeeMost has made substantial additions to its engineering and sales teams and has been recognized as a Cisco premier partner and integrator. Furthermore, during the past eight months, VeeMost has achieved four Cisco advanced specializations: Advanced Enterprise Network Architecture, Advanced SP Architecture, Advanced Collaboration Architecture, and Advanced Security Architecture. VeeMost has become one of the few technology companies nationwide to achieve four or more Cisco advanced specializations, putting it on the path to becoming a Cisco Gold Integrator Partner.
VeeMost is committed to becoming a strategic partner for Cisco and other industry leaders by providing deep technical expertise in a variety of disciplines. VeeMost will also continue to achieve a high level of customer satisfaction by harnessing the power of the cloud and automation, helping organizations achieve enterprise growth and address cybersecurity concerns, virtual work requirements, application cloud modernization, infrastructure requirements, and more.
Worldwide spending on public cloud services in 2022 was $490.3 billion, and it is forecasted to increase by 21% in 2023. Aiming to capture a significant portion of the cloud market share, VeeMost will be launching its own innovative cloud services and solutions in the second quarter of 2023, making it publicly available to organizations and consumers. Furthermore, VeeMost will continue to provide full lifecycle management services for customers' digital transformation journeys to the cloud. This service includes initial consultation and assessment and ends with full migration and management of cloud services, utilizing an iterative continuous improvement approach to infrastructure modernization.
As a result of cyber security incidents increasing at an exponential rate, organizations spent a collective $188.3 billion on information security products and services in 2022. In comparison with last year, cyber security spending is expected to increase by 12.4%. VeeMost has strategic alliances with most industry-leading security vendors, including Palo Alto Networks, Cisco Systems, and many more. In addition to providing strategic consulting and planning services, VeeMost offers implementation services, managed services, and technical services to organizations seeking to mitigate cyber security threats, meet regulatory requirements, and keep their businesses running smoothly. Our 24x7x365 NOC/SOC operation monitors our customers' networks and security infrastructures, detects threats using AI and machine learning algorithms, and mitigates issues immediately to ensure seamless operations.
Due to VeeMost's strategy on multi-year and long-term revenue streams and a current client retention rate of over 98%, the company is well positioned for short-, medium-, and long-term market penetration success and explosive growth. Aside from organic growth, VeeMost intends to acquire technology companies and cyber security companies as wholly owned subsidiaries. We are currently in active discussions with two potential acquisition targets with whom we anticipate reaching an agreement in the near future.
In the words of VeeMost's CEO Melvin Ejiogu, "I am ecstatic with what we accomplished in 2022 and look forward to what lies ahead in 2023, which appears to be shaping up to be an extremely successful year for the company. Over the years, VeeMost has developed a high level of technical expertise across the entire Cisco Portfolio, as well as multiple advanced specializations. Additionally, we have expanded our relationship with other leading vendors, such as Palo Alto. These achievements demonstrate and validate our ability to collaborate and innovate technology solutions at scale for our customers and deliver a high level of customer support."
Safe Harbor Statement
This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. You can identify these statements by the use of the words "may," "will," "should," "plans," "expects," "anticipates," "continue," "estimates," "projects," "intends," and similar expressions. Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those projected or anticipated. These risks and uncertainties include, but are not limited to, the Company's ability to successfully execute its expanded business strategy, including by entering into definitive agreements with suppliers, commercial partners and customers; general economic and business conditions, effects of continued geopolitical unrest and regional conflicts, competition, changes in technology and methods of marketing, delays in completing various engineering and manufacturing programs, changes in customer order patterns, changes in product mix, continued success in technical advances and delivering technological innovations, shortages in components, production delays due to performance quality issues with outsourced components, regulatory requirements and the ability to meet them, government agency rules and changes, and various other factors beyond the Company's control.
CONTACT:
VeeMost Technologies, LTD
info@veemost.com
GDVM ! GREAT VOLUME HERE !
QBIO ! THATS GREAT ! BB pinching hard here on 5 min watching bb"s to start opening here the right way i hope .......5 min >>>
https://www.barchart.com/stocks/quotes/QBIO/technical-chart?plot=CANDLE&volume=total&data=I:5&density=H&pricesOn=1&asPctChange=0&logscale=0&im=5&indicators=BBANDS(20,2);SMA(20);SMA(50);SMA(100);SMA(200);ACCUM;AROONOSC(25);ATR(14);CHKMF(20);STOFA(14,3);MFI(14,100);MACD(12,26,9);RSI(14,100);TRIX(3.3);ADXMOD(14);AROON(25)&sym=QBIO&grid=1&height=500&studyheight=100
QBIO ! SKIN IN THE GAME ! These two have shares as far as i can tell !
TRANS DATE FILER OWNERSHIP TYPE PRICE SHARES
05/26/2022 ROSENSTADT WILLIAM S
Officer Direct Acquisition (Non Open Market) 0.10 250,000
05/26/2022 CORIN DENIS
Officer Direct Acquisition (Non Open Market) 0.10 200,000
https://www.qbiomed.com/team
EMGE ! BUST THAT .0084 GAME-ON !!
QBIO ! FINALLY TURNING-UP HERE ! MACD crossed on the 5 min needs volume now >>> chart
https://www.barchart.com/stocks/quotes/QBIO/technical-chart?plot=CANDLE&volume=total&data=I:5&density=H&pricesOn=1&asPctChange=0&logscale=0&im=5&indicators=BBANDS(20,2);SMA(20);SMA(50);SMA(100);SMA(200);ACCUM;AROONOSC(25);ATR(14);CHKMF(20);STOFA(14,3);MFI(14,100);MACD(12,26,9);RSI(14,100);TRIX(3.3);ADXMOD(14);AROON(25)&sym=QBIO&grid=1&height=500&studyheight=100
EMGE ! GET=IT BEFORE BREAKS A PENNY ! Very nice news.......gl
QBIO ! ABOUT TO BLOW-UP AGAIN HERE ! MACD just crossed on the 5 min watch for top boli to start to open soon at .049 >>>
https://www.barchart.com/stocks/quotes/QBIO/technical-chart?plot=CANDLE&volume=total&data=I:5&density=H&pricesOn=1&asPctChange=0&logscale=0&im=5&indicators=BBANDS(20,2);SMA(20);SMA(50);SMA(100);SMA(200);ACCUM;AROONOSC(25);ATR(14);CHKMF(20);STOFA(14,3);MFI(14,100);MACD(12,26,9);RSI(14,100);TRIX(3.3);ADXMOD(14);AROON(25)&sym=QBIO&grid=1&height=500&studyheight=100
QBIO ! CHECK HIM-OUT !! https://www.bloomberg.com/profile/person/16392594
Pay attention to the boards he is on .... OMG !! BILLIONS ! LONE PINE HOLDINGS !
https://qbiomed.com/team
David Laskow-Pooley ! Work with ABBOTT LABS ! WOW
NEW YORK, February 10, 2023 - Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector, asset Uttroside B – is expected to receive a patent in the United States, adding to the already issued patents in Korea, Canada and Japan. In addition, recent results from pre-clinical pharmacokinetic testing have been very encouraging and the data supports advancing the program. Uttroside B shows tremendous value in the Liver Cancer Market. Uttroside B has also received Orphan Drug designation from the FDA.
The America Cancer Society (www.cancer.org) reported in this year alone, an estimated 42,000 adults in the United States will be diagnosed with primary liver cancer. It is also estimated that 30,000 deaths from this disease will occur this year. The 5-year survival rate is 20%, compared to just 3% 40 years ago. For the 44% of people who are diagnosed with liver cancer at an early stage, the 5-year survival rate is 34%. There is significant demand for better therapeutic alternatives in the space.
Q BioMed announced in 2021 that it has received Orphan Drug Status from the FDA. Q BioMed Inc. is prosecuting patents in multiple jurisdictions and has received patents from Canada, Korea and Japan and has now received notice of an allowable patent in the USA. The Patent is titled "Uttroside-B and Derivatives Thereof as Therapeutics for Hepatocellular Carcinoma (HCC)". Q BioMed has the exclusive rights to the technology through an agreement with the Rajiv Gandhi Centre for Biotechnology, an Autonomous Institute under the Department of Biotechnology, Government of India, and the Oklahoma Medical Research Foundation.
The global liver cancer drug market size was valued at US$824 Million in 2020 and is anticipated to grow at a CAGR of 29.4% during forecast period 2021 to 2030. In early pre-clinical investigation Q BioMed’s Uttroside-B showed ten times the cytotoxicity against HCC, which is the toxicity caused due to the action of the chemotherapeutic agent on living cancer cells, as compared to the current standard of care drug at the time. Currently, there are only two approved first-line mono therapies and a combination first-line therapy for HCC. Challenges with current treatments include patients becoming resistant to the specific drugs, adverse side effects, and high costs.
About Q BioMed Inc.
Q BioMed Inc. is a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. Q BioMed provides these target assets the strategic resources, developmental support, and expansion capital needed to ensure they meet their developmental potential, enabling them to provide products to patients in need. Please visit http://www.QBioMed.com and sign up for regular updates.
Q BioMed Media Contact:
Denis Corin CEO
https://www.qbiomed.com/news-and-media/news-2023/237-q-biomed-inc-chemotherapeutic-uttroside-b-receives-notice-of-allowance-for-patent-from-united-states-patent-office
QBIO !! HIGH-LIGHTED !
The researchers highlight Utt-B as a promising anti-HCC drug, owing to its enhanced therapeutic efficacy and pharmacological safety over sorafenib, the first-line treatment option for HCC.
This innovation has been granted a patent from the US, Canada, Japan and South Korea and has been conferred 'Orphan Drug' status against HCC by the U.S. FDA.
Bullish
BULLISH
QBIO ! STILL RIDING TOP BOLI ! On 5 min >>>
https://www.barchart.com/stocks/quotes/QBIO/technical-chart?plot=CANDLE&volume=total&data=I:5&density=H&pricesOn=1&asPctChange=0&logscale=0&im=5&indicators=BBANDS(20,2);SMA(20);SMA(50);SMA(100);SMA(200);ACCUM;AROONOSC(25);ATR(14);CHKMF(20);STOFA(14,3);MFI(14,100);MACD(12,26,9);RSI(14,100);TRIX(3.3);ADXMOD(14);AROON(25)&sym=QBIO&grid=1&height=500&studyheight=100
QBIO ! BUST THAT 200SMA COULD SEE .20-TODAY !!
QBIO ! YOU KNOW HOW TO PICK-EM BUDDY !! Lets pierce that 200 sma on the daily .045 watching........hang-on-to-your-hats-folks !!
QBIO ! LOVE-IT ! ROCK-IN NOW !!
LOVE THIS GUY ! Supported me when my son was dying from cancer !!
get-lost ! many platforms exist now ! simple !!
QBIO ! DEPENDS LIKE HOLD ON TO YOUR-CHIT ! We have been at top of bb all weekend. Many more other boards as well dont get me wrong we will lift-off at are 50sma on daily sometime. I can tell you it looks like big undervalue here an it will be corrected . Glad your here to enjoy ~~... The tide has turned to many eyes turning to take a peek !!
QBIO ! GREAT FIND HELTER SKELTER ! I am very excited for tomorrow an coming weeks im staying long an strong here. Hope your in GDV# everybody should have some of that one as well. Thanks again you rock great find.....gl
https://qbiomed.com/team
David Laskow-Pooley ! Work with ABBOTT LABS ! WOW
QBIO ! CHECK HIM-OUT !! https://www.bloomberg.com/profile/person/16392594
Pay attention to the boards he is on .... OMG !! BILLIONS ! LONE PINE HOLDINGS !!
QBIO ! A TRUE DIAMOND IN THE RUFF ! Thanks Helter you are the man so glad i listened to you... https://www.otcmarkets.com/otcapi/company/research/244359/content